Comparative Evaluation of the Safety and Efficacy of Transapical Beating-Heart Septal Myectomy versus Mavacamten (CAMZYOS®) in the Treatment of Obstructive Hypertrophic Cardiomyopathy: A Prospective, Multicenter, Randomized Controlled, Superiority Clinical Trial (ChiCTR) - Oct 16, 2026 - P=N/A | N=208 | Not yet recruiting | Sponsor: Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and Technology; Vass Medical Technology Co. , Ltd | N=128 ➔ 208
Enrollment change • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy • TNNI3
|